Veracyte nabs $45M from Visium Healthcare Partners to further grow molecular diagnostics business
The next step for the company is to focus on its Percepta Bronchial Genomic Classifier - this was picked up back in 2014 when it brought in $21 million in a deal with Allegro Diagnostics. This test allows doctors to look at 23 genes in cells lining the respiratory tract to better diagnose lung cancer.